12/16/2024 4:05 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Mayersohn Joel David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:05 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Mazur Leonard L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:06 PM | Bartushak Jaime (Reporting) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:06 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) MCGRATH DENNIS M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:07 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Dutia Suren G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:07 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Webb Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:08 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Smith Robert Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/16/2024 3:09 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:09 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Holuka Eugene Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 4:08 PM | CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Oncology (Subject) Hudson Bay Capital Management LP (Filed by)
| Form SC 13G/A | |
09/13/2024 7:30 AM | CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:15 PM | CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 8:23 AM | CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Oncology (Subject) WOLVERINE ASSET MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
08/30/2024 3:05 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4/A | |
08/16/2024 4:25 PM | CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 3:34 PM | CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Oncology (Subject) Citius Pharmaceuticals, Inc. (Filed by)
| Form SC 13D | |
08/15/2024 11:53 AM | 10XYZ Holdings LP (Filed by) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Oncology (Subject)
| Form SC 13D/A | |
08/14/2024 5:19 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Webb Carol (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:19 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Citius Pharmaceuticals, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:20 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) MCGRATH DENNIS M (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:20 PM | Bartushak Jaime (Reporting) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:21 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Mazur Leonard L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:22 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Czuczman Myron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:23 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:23 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Smith Robert Joseph (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:24 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Dutia Suren G (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:24 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Webb Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:25 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Citius Pharmaceuticals, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:26 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) MCGRATH DENNIS M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:26 PM | Bartushak Jaime (Reporting) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:27 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Mazur Leonard L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:28 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Czuczman Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:28 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:29 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Oncology (Issuer) Dutia Suren G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:33 PM | CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Oncology (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
08/09/2024 3:22 PM | CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) CITIUS ONCOLOGY, INC. (Filer) Citius Oncology (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024 7:45 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 2:39 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 2:40 PM | TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form 425 | |
07/14/2024 11:15 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form EFFECT | |
07/12/2024 4:20 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 424B3 | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
07/11/2024 2:50 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form S-4/A | |
07/11/2024 5:16 AM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form S-4/A | |
06/18/2024 12:35 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 12:36 PM | TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form 425 | |
06/17/2024 4:30 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form S-4/A | |
06/06/2024 4:28 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 4:29 PM | TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form 425 | |
05/21/2024 2:07 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 4:27 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024 3:24 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form NT 10-Q | |
04/29/2024 3:45 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:46 PM | TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form 425 | |
04/16/2024 4:00 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/02/2024 10:08 AM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form NT 10-K | |
02/13/2024 7:09 PM | MIZUHO FINANCIAL GROUP INC (Filed by) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form SC 13G | |
02/08/2024 3:07 PM | TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject) WOLVERINE ASSET MANAGEMENT LLC (Filed by)
| Form SC 13G | |
02/05/2024 2:37 PM | Space Summit Capital LLC (Filed by) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) TenX Keane Acquisition (Subject) Citius Oncology (Subject)
| Form SC 13G/A | |
01/30/2024 4:25 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form S-4/A | |
01/10/2024 3:42 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 2:21 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form DEFA14A | |
01/08/2024 3:46 PM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form DEF 14A | |
12/28/2023 11:39 AM | TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) TenX Keane Acquisition (Filer) Citius Oncology (Filer)
| Form PRE 14A | |